The characterisation of hepatic mitochondrial function in patients with non-alcoholic fatty liver disease (NAFLD) using the 13C-ketoisocaproate breath test
The characterisation of hepatic mitochondrial function in patients with non-alcoholic fatty liver disease (NAFLD) using the 13C-ketoisocaproate breath test
Hepatic mitochondrial function (HMF) assessed by the 13C-ketoisocaproate
breath test (13C-KICA BT) has been previously shown to be
significantly associated with the severity of biopsy proven non-alcoholic fatty
liver disease (NAFLD). However, it is uncertain whether any perturbation in HMF
relates specifically to severity of liver disease or factors associated with
metabolic syndrome within non-alcoholic fatty liver disease (NAFLD). Our aim
was to investigate whether there was any change in HMF assessed by 13C-KICA
BT in patients with NAFLD compared to control subjects, and to assess the
factors that are independently associated with HMF.
Methods: 77 patients with NAFLD and 11 healthy control subjects were
studied. HMF was assessed using 13C-KICA BT and expressed as
cumulative % 13C-dose recovered on breath over 1hr (cPDR over 1hr).
Liver fat and fibrosis was assessed by transient elastography. Multi-variable
linear regression modelling was undertaken to test the independence of
associations with HMF.
Results: HMF (cPDR over 1hr) was lower in NAFLD compared to controls
[13.4% (4.8) v. 21.0% (6.3); p<0.0001)]. In NAFLD, HMF was lower in patients
with diabetes versus no diabetes [12.7% (3.4) v. 14.3% (6.1); p=0.003)].
Regression modelling showed age (β = -0.08; p=0.01), waist circumference (β =
-0.08; p=0.01), hip circumference (β = -0.04; p=0.01), aspartate
aminotransferase (AST) (β = -0.05; p=0.01) and diabetes status (β = -1.81;
p=0.01) were independently associated with HMF (R2 = 41.5%; p<0.0001).
Conclusions: In patients with NAFLD (compared
to healthy subjects), there was a reduction in HMF assessed by the 13C-KICA
BT. Furthermore, in patients with NAFLD, HMF is independent and inversely
associated with age, waist and hip circumference, AST and diabetes status.
1-7
Afolabi, Paul
757e7f01-664c-493e-bc51-c6a2c933dc22
Scorletti, Eleonora
42bb0659-ac67-4a73-bf36-a881fe6c1563
Smith, Debbie E.
b41c2f97-269c-4a50-ba95-830e823cc7df
Almehmadi, Amal
3721de0d-a04b-4741-af38-0c294f0076af
Calder, Philip
1797e54f-378e-4dcb-80a4-3e30018f07a6
Byrne, Christopher
1370b997-cead-4229-83a7-53301ed2a43c
19 July 2018
Afolabi, Paul
757e7f01-664c-493e-bc51-c6a2c933dc22
Scorletti, Eleonora
42bb0659-ac67-4a73-bf36-a881fe6c1563
Smith, Debbie E.
b41c2f97-269c-4a50-ba95-830e823cc7df
Almehmadi, Amal
3721de0d-a04b-4741-af38-0c294f0076af
Calder, Philip
1797e54f-378e-4dcb-80a4-3e30018f07a6
Byrne, Christopher
1370b997-cead-4229-83a7-53301ed2a43c
Afolabi, Paul, Scorletti, Eleonora, Smith, Debbie E., Almehmadi, Amal, Calder, Philip and Byrne, Christopher
(2018)
The characterisation of hepatic mitochondrial function in patients with non-alcoholic fatty liver disease (NAFLD) using the 13C-ketoisocaproate breath test.
Journal of Breath Research, 12 (4), , [046002].
(doi:10.1088/1752-7163/aacf12).
Abstract
Hepatic mitochondrial function (HMF) assessed by the 13C-ketoisocaproate
breath test (13C-KICA BT) has been previously shown to be
significantly associated with the severity of biopsy proven non-alcoholic fatty
liver disease (NAFLD). However, it is uncertain whether any perturbation in HMF
relates specifically to severity of liver disease or factors associated with
metabolic syndrome within non-alcoholic fatty liver disease (NAFLD). Our aim
was to investigate whether there was any change in HMF assessed by 13C-KICA
BT in patients with NAFLD compared to control subjects, and to assess the
factors that are independently associated with HMF.
Methods: 77 patients with NAFLD and 11 healthy control subjects were
studied. HMF was assessed using 13C-KICA BT and expressed as
cumulative % 13C-dose recovered on breath over 1hr (cPDR over 1hr).
Liver fat and fibrosis was assessed by transient elastography. Multi-variable
linear regression modelling was undertaken to test the independence of
associations with HMF.
Results: HMF (cPDR over 1hr) was lower in NAFLD compared to controls
[13.4% (4.8) v. 21.0% (6.3); p<0.0001)]. In NAFLD, HMF was lower in patients
with diabetes versus no diabetes [12.7% (3.4) v. 14.3% (6.1); p=0.003)].
Regression modelling showed age (β = -0.08; p=0.01), waist circumference (β =
-0.08; p=0.01), hip circumference (β = -0.04; p=0.01), aspartate
aminotransferase (AST) (β = -0.05; p=0.01) and diabetes status (β = -1.81;
p=0.01) were independently associated with HMF (R2 = 41.5%; p<0.0001).
Conclusions: In patients with NAFLD (compared
to healthy subjects), there was a reduction in HMF assessed by the 13C-KICA
BT. Furthermore, in patients with NAFLD, HMF is independent and inversely
associated with age, waist and hip circumference, AST and diabetes status.
Text
Original amended manuscript submission
- Accepted Manuscript
More information
Accepted/In Press date: 26 June 2018
e-pub ahead of print date: 26 June 2018
Published date: 19 July 2018
Identifiers
Local EPrints ID: 421989
URI: http://eprints.soton.ac.uk/id/eprint/421989
PURE UUID: 53034d8d-cbcd-41a5-99ee-e38a559d4aed
Catalogue record
Date deposited: 12 Jul 2018 16:30
Last modified: 16 Mar 2024 06:48
Export record
Altmetrics
Contributors
Author:
Paul Afolabi
Author:
Eleonora Scorletti
Author:
Debbie E. Smith
Author:
Amal Almehmadi
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics